Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


4th International Early Rail Conference Honours UCL Corporate Partnerships

8 October 2010

Early Rail conference

Further to the huge success of the 4th International Early Rail Conference in 2008, and the Trevithick Bicentennial Exhibition and Commemorative Dinner, UCL has been honoured in the long-awaited book of the Conference, which was recently published.

The Conference was invited to form the fulcrum of the season of activities,  organised and hosted by the UCL Centre for Transport Studies and UCL Business Partnerships, in collaboration with The Science Museum and sponsored by O2 and Eurostar.

The Introduction to the volume offers high praise for the UCL Business Partnerships initiative:

"The success of the conference - arguably the best yet - was due in no small part to the personal attention given by Dr Anna Clark, UCL's Director of Business Partnerships. Her vision and drive throughout all stages of planning smoothed away any problems or difficulties in a spirit of great friendship. The facilities and arrangements laid on for us by the College, and the welcome extended to us, were much appreciated."

Grahame Boyes, Editor.

Read more information about the event here.